© Product: CIPROFLOXACIN HYDROCHLORIDE A. No: BICPHIFP/2- Mfg. Date: July, 2022 Citi Pharma Ltd. oot Bi PICPHCA-002/01 CERTIFICATE OF ANALYSIS -0076 Batch No: CPH2207076 Batch Siz Exp. Date: July, 2025 300.0Kgs TEST SPECIFICATIONS RESULTS Physical Description | White to light yellow crystalline powder White to Light yellow - + | ___ crystalline powder. | A. IR ~ Complies | Identification Chloride Complies Freely Soluble in water. Slightly soluble | in acetic acid and methanol, very slightly soluble in dehydrated alcohol, Practically, insoluble in acetone, in Complies | acetonitrile, in ethyl acetate, in hexane | and methylene chloride, Appearance of |__| Solution is clear and not more intensely — [| ‘Solution | colored than reference solution | Complies | Sulphated Ash! ; | Residue on ignition _| Maximum 0.1% ee pH of 2.5% Solution | 3.0 374 | Water by K.F(wiw) | 4.7 — 6.7% 6.34% Sulphate | Maximum0.04% Complies | Impurity A NMT 0.2% Complies Fioroquinolonic acid Impurity E NMT0.3% Not Detected Related Substances s B,C,D IMT 0.2% Not Detected qa NMT 0.10% Not Detected | Assay (on Anhydrous basis} Remarks: Thi Date: Analyzed by: 42 7 Checked by: _ Bee Total impurity | NMT 0.5% | ) | 98.0% to 102.0% CyHisFNOsHC! | i oduct complies with BP/USP si Not Detected 98.95 % cifications. RELEASED pnproved by: C Nue_ Date: shy Date: 20-22 UNCONTROLLED COPY Factory: 3K M, Head Balloki Road, Bhai Pheru, Distt. Kasur Pakistan Tet 192.49-4510872, 192 99-4813192 ‘email mctipharma.com pk website: wuav pharm com pk